Reported Jul 29, 2026 · Ongoing · Updated Sep 16, 2026
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only,…
Major Pharmaceuticals
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Major Pharmaceuticals · 7000 Cardinal Pl · Dublin, OH · 43017-1091
Is this the product you have?
- Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only
- Packaged and Distributed byMAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA
- NDC0904-6951-61
- Lot codes and dates
Lot# N02172exp 07/2026N02296N02288Exp. Date 12/2026
This recall covers 12 products
The agency filed one notice per product. You are reading one of them; the other 11 are below.
Where it was sold
- Nationwide
Why it was recalled
Subpotent Drug
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Major Pharmaceuticals recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.